Could These Drugs Be a Cure For Lung Cancer?

HYANNIS – You may have noticed an uptick in the advertising of two new immunotherapy drugs, Optivo® (nivolumab) and Keytruda® (pembrolizumab), which are changing the conversation about treatment of metastatic non-small cell lung cancer. That’s because for the first time in years, these drugs are showing promise in…
.